期刊文献+

血浆中格列齐特的HPLC测定及药代动力学研究 被引量:13

Determination and Pharmacokinetics Study of Gliclazide in Human Plasma by HPLC
下载PDF
导出
摘要 本文采用ZorbaxC8色谱柱,甲醇-0.2%冰醋酸(62:38)为流动相,229nm为检测波长,甲苯磺丁脲为内标,乙酸乙酯萃取血浆药物,建立了测定血浆中格列齐特浓度的HPLC法。该法简便、灵敏、快速、准确,格列齐特在0.25~8.0μ/ml的浓度范围内线性关系良好(r=0.9991),检测限为0.15μg/ml(S/N=3:l),平均回收率为97.60%,不同浓度水平测定结果的日内和日间精密度(RSD)均小于10.0%。 This paper reports a RP-HPLC method using tolbutamide as internal standard (IS) for the determination of gliclazide (GZ).The LA-3A HPLC instrument used a Zorbax-C8 column (25cm×4. 6mmm 10μm), the mobile phase consisted of methanol-0. 2% acetic acid (62:38) and the flow rate was 0.9ml/min. The UV detection wavelength was 229nm, column temperature was 30℃ and the drug in plasma was extracted by ethyl acetate. This method is simple, sensitive and rapid. Within 0. 25~8.0μg/ml, GZ had a good linearity (r=0. 999l). The meanrecovery of GZ was 97. 60%, the detection limit was 0.15μ/ml (S/N=3 : l) . The withinday precision and day-to-day precision RSD were less than 10. 0% at three drug levels. This method has been used to investigate pharmacokinetics and bioavailability of GZ in healthy human volunteers.
出处 《药物分析杂志》 CAS CSCD 北大核心 1996年第3期157-160,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 格列齐特 血浆 高效液相色谱法 药代动力学 gliclazide, human plasma, HPLC. pharmacokinetics. bioavailability
  • 相关文献

参考文献4

二级参考文献3

共引文献9

同被引文献64

引证文献13

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部